GoodRx could seek up to $969M in IPO
GoodRx priced its long-awaited IPO between $24 and $28 per share. The company could raise up to $969 million in funding.
GoodRx priced its long-awaited IPO between $24 and $28 per share. The company could raise up to $969 million in funding.
The 5-year partnership has helped grant 450 wishes across the country for kids with critical illnesses.
Small practices play a critical role in healthcare delivery, but they cannot continue to absorb ever-increasing administrative demands without consequences.